OnKure Therapeutics annual shares outstanding
2020
2021
2022
2023
OnKure Therapeutics Shares Outstanding History (OKUR)
OnKure Therapeutics reported 33.4M shares outstanding at the end of fiscal 2023.
View full OnKure Therapeutics company overviewOnKure Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 33.4M | 8.7M | +35.31% |
| 2022 | 2022-12-31 | 24.7M | 244,163 | +1.00% |
| 2021 | 2021-12-31 | 24.5M | 22.4M | +1091.16% |
| 2020 | 2020-12-31 | 2.1M | — | — |
OnKure Therapeutics quarterly shares outstanding
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | 3.3M | −30.5M | −90.13% |
| Q2 2024 | 2024-06-30 | 33.4M | −379,980 | −1.12% |
| Q1 2024 | 2024-03-31 | 33.4M | 8.3M | +33.11% |
| Q4 2023 | 2023-12-31 | 33.4M | 8.7M | +35.31% |
| Q3 2023 | 2023-09-30 | 33.9M | 9.3M | +38.09% |
| Q2 2023 | 2023-06-30 | 33.8M | 9.3M | +38.08% |
| Q1 2023 | 2023-03-31 | 25.1M | 648,880 | +2.65% |
| Q4 2022 | 2022-12-31 | 24.7M | 244,163 | +1.00% |
| Q3 2022 | 2022-09-30 | 24.5M | 121,924 | +0.50% |
| Q2 2022 | 2022-06-30 | 24.5M | 190,947 | +0.79% |
| Q1 2022 | 2022-03-31 | 24.5M | 22.3M | +1051.68% |
| Q4 2021 | 2021-12-31 | 24.5M | 22.4M | +1091.16% |
| Q3 2021 | 2021-09-30 | 24.4M | — | — |
| Q2 2021 | 2021-06-30 | 24.3M | — | — |
| Q1 2021 | 2021-03-31 | 2.1M | — | — |
| Q4 2020 | 2020-12-31 | 2.1M | — | — |
OnKure Therapeutics shares outstanding trends
Across the available reported history, OnKure Therapeutics's shares outstanding moved from 24.7M to 33.4M, a change of 8.7M. The latest reported quarter, Q3 2024, shows 3.3M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OnKure Therapeutics filings at SEC.gov ↗